Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report

Genotype-negative MEN1 typically has a favorable clinical course without a third primary MEN1 manifestation. However, the present case had a symptomatic macroprolactinoma with an apparent elevated glucose level and three manifestations of tumors (pituitary, parathyroid, and adrenal) with invasive PTC, and a delayed diagnosis could have caused crucial deterioration. Clinicians should pay attention to the clinical features of MEN1 including glucose intolerance. In such cases, the treatment of endocrine disorders can lead to the normalization of the glucose level.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2024-12-12
DOI
https://doi.org/10.3389/fendo.2024.1498991
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report

Mutsuo Yamada, Yuto Yamazaki, Kazuhiro Sugimoto, Yasuhisa Nomura et al.
Frontiers in Endocrinology
Neuroendocrine Tumor Research Advances
article

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report

Mutsuo Yamada, Yuto Yamazaki, Kazuhiro Sugimoto, Yasuhisa Nomura, Naohiro Sekikawa, Ryota Wada, Minoru Inoue, Naoki Hattori, Haremaru Kubo
article en

Abstract

Genotype-negative MEN1 typically has a favorable clinical course without a third primary MEN1 manifestation. However, the present case had a symptomatic macroprolactinoma with an apparent elevated glucose level and three manifestations of tumors (pituitary, parathyroid, and adrenal) with invasive PTC, and a delayed diagnosis could have caused crucial deterioration. Clinicians should pay attention to the clinical features of MEN1 including glucose intolerance. In such cases, the treatment of endocrine disorders can lead to the normalization of the glucose level.

Frontiers in EndocrinologyVol. 15
Kansai Medical University (JP), Tohoku University (JP), Ohta Nishinouchi Hospital (JP)
Good health and well-being
Openalex Percentile: Top 66%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report — Mutsuo Yamada, Yuto Yamazaki, et al. · Frontiers in Endocrinology (2024) | TGRS Research Map | TGRS